Genocea to Present at the 32nd Annual Oppenheimer Healthcare Conference
CAMBRIDGE, Mass., March 14, 2022 -- Genocea Biosciences, Inc. , a biopharmaceutical company developing next-generation neoantigen immunotherapies, today announced that Chip Clark, President... | March 14, 2022